Lv1
48 积分 2022-09-16 加入
Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy
8天前
已完结
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
8天前
已完结
肝癌术后辅助治疗中国专家共识（2023 版）
9天前
已完结
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
11天前
已完结
From core to surface: Expanding the donor pool with HBsAg-positive liver allografts
12天前
已关闭
Multidisciplinary treatment of hepatocellular carcinoma in 2023
13天前
已完结
Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis
16天前
已完结
肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)
20天前
已完结
中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)
21天前
已完结
中国肝癌肝移植受者免疫检查点抑制剂应用专家共识（2024版）
21天前
已完结
皖公网安备34019202002308
